Whitehawk Therapeutics
WHWK
78 hedge funds and large institutions have $198M invested in Whitehawk Therapeutics in 2026 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 30 increasing their positions, 10 reducing their positions, and 12 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 10
142% more first-time investments, than exits
New positions opened: 29 | Existing positions closed: 12
66% more capital invested
Capital invested by funds: $119M → $198M (+$78.5M)
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
26% more funds holding
Funds holding: 62 → 78 (+16)
14.87% more ownership
Funds ownership: 72.57% → 87.44% (+15%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
YF
Yu Fan
|
+$11.6M |
| 2 |
BlackRock
New York
|
+$6.54M |
| 3 |
ACP
Acuta Capital Partners
Redwood City,
California
|
+$5.31M |
| 4 |
ACM
ADAR1 Capital Management
Austin,
Texas
|
+$5.05M |
| 5 |
SCM
Suvretta Capital Management
New York
|
+$2.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ANC
Ames National Corp
Ames,
Iowa
|
-$1.33M |
| 2 |
Balyasny Asset Management
Chicago,
Illinois
|
-$1.09M |
| 3 |
O
OrbiMed
New York
|
-$964K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$702K |
| 5 |
Jane Street
New York
|
-$521K |
WHWK Hedge Fund Activity: Q2 2026 in Review
78 of the 8,318 institutional investors tracked by Wall St. Rank reported a position in Whitehawk Therapeutics (WHWK) for Q2 2026, worth a combined $198M — up 66% from $119M a quarter earlier.
Buyers outnumbered sellers: 29 funds opened new WHWK positions and 12 closed out — a net gain of 17 holders — while 30 added to existing stakes and 10 trimmed.
The largest buyer was Yu Fan, adding an estimated $11.6M. The largest seller was Ames National Corp, exiting entirely with an estimated $1.33M sold.
- 78 institutional investors held Whitehawk Therapeutics (WHWK) as of Q2 2026, up from 62 in Q1 2026.
- Funds reported $198M of Whitehawk Therapeutics stock for Q2 2026, up 66% quarter-over-quarter.
- 29 funds opened new Whitehawk Therapeutics positions in Q2 2026 and 12 closed out, a net change of +17 holders.
- The largest Whitehawk Therapeutics buyer in Q2 2026 was Yu Fan, an estimated $11.6M added.
- The largest Whitehawk Therapeutics seller in Q2 2026 was Ames National Corp, an estimated $1.33M sold.
Based on aggregated 13F filings for Q2 2026.